These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1233 related items for PubMed ID: 10757081

  • 1. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
    Bierman PJ, Abe F, Buyukberber S, Ino K, Talmadge JE.
    In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Time-course of the recovery of cellular immune function after high-dose chemotherapy and peripheral blood progenitor cell transplantation for high-grade non-Hodgkin's lymphoma.
    Scheid C, Pettengell R, Ghielmini M, Radford JA, Morgenstern GR, Stern PL, Crowther D.
    Bone Marrow Transplant; 1995 Jun; 15(6):901-6. PubMed ID: 7581089
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Reconstitution of peripheral blood lymphocytes in patients treated with bone marrow transplantation: comparison between allogeneic and autologous transplantation].
    Parra C, Roldán E, Rodríguez C, Pérez de Oteyza J, Oteho E, López J, Maldonado MS, García Laraña J, Muñoz A, Odriozola J, Brieva JA.
    Med Clin (Barc); 1999 Jun 12; 113(1):1-5. PubMed ID: 10422068
    [Abstract] [Full Text] [Related]

  • 7. Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation.
    Talmadge JE, Reed EC, Kessinger A, Kuszynski CA, Perry GA, Gordy CL, Mills KC, Thomas ML, Pirruccello SJ, Letheby BA, Arneson MA, Jackson JD.
    Bone Marrow Transplant; 1996 Jan 12; 17(1):101-9. PubMed ID: 8673041
    [Abstract] [Full Text] [Related]

  • 8. Reconstitution of lymphocyte subsets after peripheral blood stem cell transplantation: two-color flow cytometric analysis.
    Ashihara E, Shimazaki C, Yamagata N, Hirata T, Okawa K, Oku N, Goto H, Inaba T, Fujita N, Nakagawa M.
    Bone Marrow Transplant; 1994 Apr 12; 13(4):377-81. PubMed ID: 7912603
    [Abstract] [Full Text] [Related]

  • 9. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
    D'Arena G, Musto P, Cascavilla N, Di Giorgio G, Fusilli S, Zendoli F, Carotenuto M.
    Haematologica; 1998 Mar 12; 83(3):197-203. PubMed ID: 9573672
    [Abstract] [Full Text] [Related]

  • 10. Monocyte activation by an oral immunomodulator (bestatin) in lymphoma patients following autologous bone marrow transplantation.
    Ino K, Bierman PJ, Varney ML, Heimann DG, Kuszynski CA, Walker SA, Talmadge JE.
    Cancer Immunol Immunother; 1996 Dec 12; 43(4):206-12. PubMed ID: 9003465
    [Abstract] [Full Text] [Related]

  • 11. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
    Huang HQ, Cai QC, Shi YX, Lin XB, Wei J, Guo Y, Pan ZH.
    Ai Zheng; 2006 Aug 12; 25(8):1023-8. PubMed ID: 16965687
    [Abstract] [Full Text] [Related]

  • 12. Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation.
    Porrata LF, Inwards DJ, Lacy MQ, Markovic SN.
    Bone Marrow Transplant; 2001 Oct 12; 28(7):673-80. PubMed ID: 11704790
    [Abstract] [Full Text] [Related]

  • 13. Phenotypic and functional reconstitution of peripheral blood lymphocytes following T cell-depleted bone marrow transplantation from partially mismatched related donors.
    Lamb LS, Gee AP, Henslee-Downey PJ, Geier SS, Hazlett L, Pati AR, Godder K, Abhyankar SA, Turner MW, Lee C, Harris WG, Parrish RS.
    Bone Marrow Transplant; 1998 Mar 12; 21(5):461-71. PubMed ID: 9535038
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immunologic and clinical modifications following low-dose subcutaneous administration of rIL-2 in non-Hodgkin's lymphoma patients after autologous bone marrow transplantation.
    Lauria F, Raspadori D, Ventura MA, Rondelli D, Zinzani PL, Gherlinzoni F, Miggiano MC, Fiacchini M, Rosti G, Rizzi S, Tura S.
    Bone Marrow Transplant; 1996 Jul 12; 18(1):79-85. PubMed ID: 8831999
    [Abstract] [Full Text] [Related]

  • 17. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
    Schorlemmer HU, Bosslet K, Dickneite G, Lüben G, Sedlacek HH.
    Behring Inst Mitt; 1984 May 12; (74):157-73. PubMed ID: 6383322
    [Abstract] [Full Text] [Related]

  • 18. Immune reconstitution and production of intracellular cytokines in T lymphocyte populations following autologous peripheral blood stem cell transplantation.
    Schlenke P, Sheikhzadeh S, Weber K, Wagner T, Kirchner H.
    Bone Marrow Transplant; 2001 Aug 12; 28(3):251-7. PubMed ID: 11535992
    [Abstract] [Full Text] [Related]

  • 19. Bone marrow 'boosts' following T cell-depleted haploidentical bone marrow transplantation.
    Kline RM, Stiehm ER, Cowan MJ.
    Bone Marrow Transplant; 1996 Apr 12; 17(4):543-8. PubMed ID: 8722352
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.